Search Results

There are 2619 results for: content related to: Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial

  1. Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 6, June 2015, Pages: 1082–1090, C. Paul, J.-P. Lacour, L. Tedremets, K. Kreutzer, S. Jazayeri, S. Adams, C. Guindon, R. You, C. Papavassilis and for the JUNCTURE study group

    Version of Record online : 22 SEP 2014, DOI: 10.1111/jdv.12751

  2. You have free access to this content
    Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study

    The Journal of Dermatology

    Volume 41, Issue 12, December 2014, Pages: 1039–1046, Mamitaro Ohtsuki, Akimichi Morita, Masatoshi Abe, Hidetoshi Takahashi, Noriko Seko, Alexander Karpov, Tomohiro Shima, Charis Papavassilis, Hidemi Nakagawa and forthe ERASURE Study Japanese subgroup

    Version of Record online : 30 OCT 2014, DOI: 10.1111/1346-8138.12668

  3. You have full text access to this OnlineOpen article
    Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 777–787, D. Thaçi, J. Humeniuk, Y. Frambach, R. Bissonnette, J.J. Goodman, S. Shevade, Y. Gong, C. Papavassilis and for the STATURE study group

    Version of Record online : 16 MAY 2015, DOI: 10.1111/bjd.13814

  4. You have full text access to this OnlineOpen article
    New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors

    Dermatologic Therapy

    Volume 28, Issue 4, July/August 2015, Pages: 179–193, Anthony A. Gaspari and Stephen Tyring

    Version of Record online : 23 JUL 2015, DOI: 10.1111/dth.12251

  5. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  6. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

    British Journal of Dermatology

    Volume 172, Issue 2, February 2015, Pages: 484–493, A. Blauvelt, J.C. Prinz, A.B. Gottlieb, K. Kingo, H. Sofen, M. Ruer-Mulard, V. Singh, R. Pathan, C. Papavassilis, S. Cooper and for the FEATURE Study Group

    Version of Record online : 11 DEC 2014, DOI: 10.1111/bjd.13348

  7. You have free access to this content
    Australasian College of Dermatologists Abstracts Presented at the 48th Annual Scientific Meeting 16–19 May 2015 Adelaide, South Australia

    Australasian Journal of Dermatology

    Volume 56, Issue S2, May 2015, Pages: 1–87,

    Version of Record online : 2 APR 2015, DOI: 10.1111/ajd.12337

  8. You have free access to this content
    Abstracts

    Internal Medicine Journal

    Volume 45, Issue S2, May 2015, Pages: 1–46,

    Version of Record online : 10 MAY 2015, DOI: 10.1111/imj.12752

  9. You have free access to this content
    Australasian College of Dermatologists Abstracts Presented at the 49th Annual Scientific Meeting 14–17 May 2016 Perth, Western Australia

    Australasian Journal of Dermatology

    Volume 57, Issue S1, May 2016, Pages: 3–85,

    Version of Record online : 20 APR 2016, DOI: 10.1111/ajd.12480

  10. You have free access to this content
    Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

    British Journal of Dermatology

    Volume 168, Issue 2, February 2013, Pages: 402–411, P. Rich, B. Sigurgeirsson, D. Thaci, J.-P. Ortonne, C. Paul, R.E. Schopf, A. Morita, K. Roseau, E. Harfst, A. Guettner, M. Machacek and C. Papavassilis

    Version of Record online : 30 JAN 2013, DOI: 10.1111/bjd.12112

  11. 7th International Congress of Psoriasis: from Gene to Clinic The Queen Elizabeth II Conference Centre, London, U.K. 11th-13th December 2014

    British Journal of Dermatology

    Volume 171, Issue 6, December 2014, Pages: e105–e173,

    Version of Record online : 18 DEC 2014, DOI: 10.1111/bjd.13488

  12. You have free access to this content
    47th Annual Scientific Meeting

    Australasian Journal of Dermatology

    Volume 55, Issue S1, May 2014, Pages: 1–58,

    Version of Record online : 15 MAY 2014, DOI: 10.1111/ajd.12174

  13. You have free access to this content
    Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

    British Journal of Dermatology

    Volume 168, Issue 2, February 2013, Pages: 412–421, K.A. Papp, R.G. Langley, B. Sigurgeirsson, M. Abe, D.R. Baker, P. Konno, S. Haemmerle, H.J. Thurston, C. Papavassilis and H.B. Richards

    Version of Record online : 18 JAN 2013, DOI: 10.1111/bjd.12110

  14. You have free access to this content
    Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis

    Immunology

    Volume 141, Issue 2, February 2014, Pages: 133–142, Bruce W. Kirkham, Arthur Kavanaugh and Kristian Reich

    Version of Record online : 9 JAN 2014, DOI: 10.1111/imm.12142

  15. You have free access to this content
    Poster

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 13, Issue S1, April 2015, Pages: 111–185,

    Version of Record online : 30 MAR 2015, DOI: 10.1111/ddg.12658

  16. Short-term efficacy and safety of new biologic agents targeting IL-23/Th17 pathway for moderate to severe plaque psoriasis: a systematic review and network meta-analysis

    British Journal of Dermatology

    Accepted manuscript online: 13 JUN 2016, F. Gómez-García, D. Epstein, B. Isla-Tejera, A. Lorente, A. Vélez García-Nieto and J. Ruano

    DOI: 10.1111/bjd.14814

  17. Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 8, August 2014, Pages: 1127–1129, B. Sigurgeirsson, L. Kircik, O. Nemoto, I. Mikazans, S. Haemmerle, H.J. Thurston, C. Papavassilis and H.B. Richards

    Version of Record online : 13 DEC 2013, DOI: 10.1111/jdv.12343

  18. Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis

    Arthritis & Rheumatology

    Accepted manuscript online: 25 MAR 2016, Désirée van der Heijde, Robert B. Landewé, Philip J. Mease, Iain B. McInnes, Philip G. Conaghan, Luminita Pricop, Greg Ligozio, Hanno B. Richards and Shephard Mpofu

    DOI: 10.1002/art.39685

  19. Secukinumab treatment of plaque psoriasis shows early improvement in DLQI response – results of a phase II regimen-finding trial

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue 4, April 2016, Pages: 645–649, M. Augustin, S. Abeysinghe, U. Mallya, A. Qureshi, N. Roskell, D. McBride, C. Papavassillis and J. Gelfand

    Version of Record online : 10 DEC 2015, DOI: 10.1111/jdv.13478

  20. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study

    The Journal of Dermatology

    Shinichi Imafuku, Masaru Honma, Yukari Okubo, Mayumi Komine, Mamitaro Ohtsuki, Akimichi Morita, Noriko Seko, Naoko Kawashima, Saori Ito, Tomohiro Shima and Hidemi Nakagawa

    Version of Record online : 26 FEB 2016, DOI: 10.1111/1346-8138.13306